Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence

Therapeutic antibodies are an important tool in the arsenal against coronavirus infection. However, most antibodies developed early in the pandemic have lost most or all efficacy against newly emergent strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly those of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hastie, Kathryn M., Yu, Xiaoying, Ana-Sosa-Batiz, Fernanda, Zyla, Dawid S., Harkins, Stephanie S., Hariharan, Chitra, Wasserman, Hal, Zandonatti, Michelle A., Miller, Robyn, Maule, Erin, Kim, Kenneth, Valentine, Kristen M., Shresta, Sujan, Saphire, Erica Ollmann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083196/
https://www.ncbi.nlm.nih.gov/pubmed/37083327
http://dx.doi.org/10.1016/j.celrep.2023.112421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083196/
https://www.ncbi.nlm.nih.gov/pubmed/37083327
http://dx.doi.org/10.1016/j.celrep.2023.112421

Ejemplares similares